Lasalle Investment Management Securities LLC increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 8.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,824,622 shares of the real estate investment trust’s stock after buying an additional 290,405 shares during the quarter. Sabra Healthcare REIT comprises approximately 2.9% of Lasalle Investment Management Securities LLC’s investment portfolio, making the stock its 14th biggest position. Lasalle Investment Management Securities LLC’s holdings in Sabra Healthcare REIT were worth $73,547,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in SBRA. Rothschild Investment LLC raised its holdings in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 714 shares in the last quarter. Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT during the 4th quarter worth $29,000. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT in the third quarter worth $30,000. Finally, Larson Financial Group LLC increased its position in shares of Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the period. Institutional investors own 99.40% of the company’s stock.
Key Sabra Healthcare REIT News
Here are the key news stories impacting Sabra Healthcare REIT this week:
- Positive Sentiment: Truist Financial raised its price target on Sabra Healthcare REIT from $22 to $24 and reiterated a buy rating, signaling confidence in further upside. Benzinga
- Positive Sentiment: Citizens JMP lifted its price target from $23 to $25 and maintained a market outperform rating, suggesting analysts see additional room for the stock to climb. Benzinga
- Positive Sentiment: Sabra increased FY 2026 EPS guidance to $1.53-$1.55, above the consensus estimate of $1.50, which supports the case for stronger-than-expected earnings. Business Wire
- Positive Sentiment: The company announced a major portfolio reshaping, including plans to re-tenant properties previously leased to Avamere, which may improve occupancy stability and operational quality over time. TipRanks
- Neutral Sentiment: Zacks noted SBRA was a strong recent mover on heavy volume, but also warned that recent FFO estimate revisions could limit near-term follow-through. Zacks
Sabra Healthcare REIT Trading Down 0.3%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. The business had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.5%. Sabra Healthcare REIT’s payout ratio is presently 190.48%.
Analyst Ratings Changes
A number of research firms recently commented on SBRA. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. UBS Group set a $25.00 price objective on shares of Sabra Healthcare REIT in a research note on Wednesday. Barclays initiated coverage on shares of Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 target price on the stock. Raymond James Financial initiated coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, June 17th. They issued an “underperform” rating for the company. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.25.
Check Out Our Latest Research Report on SBRA
Sabra Healthcare REIT Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Featured Articles
- Five stocks we like better than Sabra Healthcare REIT
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
